StockDriftsStockDriftsTop 9 Omega Fund Management LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 29.14% | 1.82M | $54.1M | -23.83%(-570.00K) | $24.91(-2.54%) | 2026-06-30 | |
| NUVB | Nuvation Bio Inc. | 24.72% | 8.08M | $45.9M | +0.00%(+0) | $11.07(-43.84%) | 2026-06-30 | |
| KMTS | Kestra Med Technologies Ltd | 14% | 1.02M | $26.0M | +0.00%(+0) | $24.92(+12.44%) | 2026-06-30 | |
| BBOT | BridgeBio Oncology Therapeutics Inc. | 13.5% | 3.29M | $25.1M | +0.00%(+0) | $11.10(-18.38%) | 2026-06-30 | |
| BBNX | Beta Bionics Inc. | 11.11% | 1.32M | $20.6M | +0.00%(+0) | $12.24(+43.55%) | 2026-06-30 | |
| ALMS | Alumis Inc. | 3.66% | 241.3K | $6.8M | +0.00%(+0) | $13.30(+90.30%) | 2026-06-30 | |
| SANA | Sana Biotechnology, Inc. | 1.59% | 843.8K | $2.9M | +0.00%(+0) | $33.47(-89.39%) | 2026-06-30 | |
| IMA | ImageneBio, Inc. | 1.45% | 455.4K | $2.7M | +0.00%(+0) | $72.97(-92.00%) | 2026-06-30 | |
| ENGN | enGene Holdings Inc. | 0.82% | 876.4K | $1.5M | +0.00%(+0) | $9.45(-82.12%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | -32.70% | -69.51% | -27.69% | -80.23% |
| Top 20 Holdings Unweighted | -21.65% | -51.91% | -18.00% | -62.92% |
Omega Fund Management LLC reports $185.69M in US-listed equity holdings across 10 positions in its most recent 13F filing. Its largest disclosed positions are BCAX (29.1%), NUVB (24.7%) and KMTS (14.0%). The top 20 holdings account for 99.99% of reported assets. Its disclosed equity book has returned -69.51% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Omega Fund Management LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Omega Fund Management LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1637359). View Omega Fund Management LLC’s 13F filings on SEC